AAB-001 in Patients With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Alzheimer's Disease
Interventions
DRUG

bapineuzumab

IV, Q13w

OTHER

placebo

IV Q13w

Trial Locations (26)

10032

Sergievsky Center, Columbia University, New York

14620

University of Rochester / Monroe Community Hospital, Rochester

15213

University of Pittsburgh, Pittsburgh

20057

Georgetown University Medical Center, Washington D.C.

27710

Department of Psychiatry and Behavioral Sciences, Durham

32224

Mayo Clinic - Department of Neurology, Jacksonville

33445

Brain Matters Research, Inc., Delray Beach

46202

Department of Neurology - Indiana University Medical Center, Indianapolis

48109

University of Michigan Health System, Department of Neurology, Ann Arbor

55905

Mayo Clinic Department of Neurology - Alzheimer's Disease Research Center, Rochester

60612

Rush Presbyterian St. Luke's Medical Center, Chicago

75390

University of Texas Southwestern Medical Center, Dallas

77030

Baylor College of Medicine, Houston

85351

Cleo Roberts Center for Clinical Research / Sun Health Research Institute, Sun City

90720

Pharmacology Research Institute, Los Alamitos

91324

Pharmacology Research Institute, Northridge

92697

UC Irvine, Irvine

97239

Oregon Health and Science University, Portland

98108

University of Washington, Seattle

Unknown

UCSD Shiley-Marcos Alzheimer's Disease Research Center, San Diego

Memory & Aging Center, UCSF, San Francisco

06510

Yale University School of Medicine, New Haven

02115

Behavioral Neurology, Boston

07740

The Memory Enhancement Center, Long Branch

02906

Memory and Aging Program, Butler Hospital, Providence

05201

Clinical Neuroscience Research Associates, Inc., Bennington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

JANSSEN Alzheimer Immunotherapy Research & Development, LLC

INDUSTRY